[Translation] A multicenter, randomized, double-blind, controlled phase III clinical trial of allogeneic human adipose-derived mesenchymal progenitor cell injection (AlloJoin) for the treatment of knee osteoarthritis
探索和评价CBMG研发和生产的异体人源脂肪间充质祖细胞注射液(以下简称“AlloJoin®”)治疗膝骨关节炎(KOA)方面的有效性和安全性。
[Translation] To explore and evaluate the efficacy and safety of allogeneic human adipose-derived mesenchymal progenitor cell injection (hereinafter referred to as "AlloJoin®") developed and produced by CBMG in the treatment of knee osteoarthritis (KOA).